The popularity of Viagra initially sparked a surge for major pharmaceutical companies, however recent developments present a uncertain scenario for investors. Lower-cost versions are reducing profits, and persistent https://arunlcbd062354.blogpostie.com/62393737/the-blue-pill-and-big-pharma-a-volatile-play